T Cell Therapy Targeted on HLA-A02 Restricted HIV Antigen Epitopes: An Open Label Cellular Therapy Trial Using CD8+ T Cell

Objective: To test the safety and efficacy of a T cell therapy de novo targeting HLA-A02 restricted HIV antigen epitopes.Design: This was a prospective open label clinical trial, which enrolled 28 HIV+ participants and 24 of them finished the trial. The study was publicly registered at Chinese Clini...

Full description

Bibliographic Details
Main Authors: Sai Liu, Jianping Sun, Zhen Li, Ling Qin, Guihai Liu, Kang Li, Hao Wu, Tao Dong, Yonghong Zhang
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-03-01
Series:Frontiers in Immunology
Subjects:
HIV
Online Access:https://www.frontiersin.org/article/10.3389/fimmu.2019.00437/full